Drug Shortage Report for TEVA-SALBUTAMOL STERINEBS P.F.
| Report ID | 153186 |
| Drug Identification Number | 01926934 |
| Brand name | TEVA-SALBUTAMOL STERINEBS P.F. |
| Common or Proper name | SALBUTAMOL 1MG/ML NEBS |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | SALBUTAMOL |
| Strength(s) | 1MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INHALATION INHALATION |
| Packaging size | 20 x 2.5ml |
| ATC code | R03AC |
| ATC description | ADRENERGICS, INHALANTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2022-01-19 |
| Estimated end date | 2022-02-28 |
| Actual end date | 2022-02-16 |
| Shortage status | Resolved |
| Updated date | 2022-02-17 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2022-02-17 | French | Compare |
| v3 | 2022-02-17 | English | Compare |
| v2 | 2022-01-20 | French | Compare |
| v1 | 2022-01-20 | English | Compare |
Showing 1 to 4 of 4